Aldaak, Mawada
Suliman, Hayat M.
Abd-Elgadir, Elsadig Elgailany
Abdoon, Iman Hassan
Article History
Received: 27 March 2022
Accepted: 2 November 2022
First Online: 14 November 2022
Declarations
:
: The study was approved by University of Khartoum, faculty of pharmacy, research board (Ethics Committee, No. 71–12-10–2020). In addition, ethical clearance was obtained from the Ministry of Health, Research Department. Permission to conduct the research was granted by the general director of Khartoum Oncology Hospital. All research was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants after a thorough explanation of the study objectives. Confidentiality and voluntary participation were assured and participants had all rights to withdraw at any time.
: Not applicable.
: The authors declare that they have no competing interests.